<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320832">
  <stage>Registered</stage>
  <submitdate>13/11/2009</submitdate>
  <approvaldate>17/11/2009</approvaldate>
  <actrnumber>ACTRN12609000987268</actrnumber>
  <trial_identification>
    <studytitle>The effect of intra-dialytic exercise training on pro-inflammatory cytokines, endothelial function and functional capacity in chronic kidney disease patients.</studytitle>
    <scientifictitle>The effect of intra-dialytic exercise training versus usual care on functional capacity, systematic inflammation, quality of life, blood vessel function and biochemistry in patients with chronic kidney disease.</scientifictitle>
    <utrn>U1111-1112-5020</utrn>
    <trialacronym>None</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic Kidney Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Exercise training (cycling) for 45 minutes, 3 times per week for 3 months at about 65% maximum.</interventions>
    <comparator>Usual Care is dialysis 3 sessions per week for approxiamtely 4 hours per session and nephrology consultations as required.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Peak Volume of oxygen (VO2) measured by incremental, maximal exercise test conducted on a cycle ergometer.</outcome>
      <timepoint>0, 3, 6 months following randomization</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life. This measurement will be made using the Kidney Disease Quality of Life (KDQOL) questionnaire.</outcome>
      <timepoint>0, 3, 6 months following randomization</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Systemic Inflammation interleukin -1(IL-1), interleukin-6 (IL-6), interleukin-10 (IL-10), tumour necrosis factor alpha (TNF-alpha) and TNF-alpha soluble receptors I and II will be measured by immunoassay.</outcome>
      <timepoint>0, 3, 6 months following randomization</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Blood vessel function by Doppler ultrasound</outcome>
      <timepoint>0, 3, 6 months following randomization</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Chronic kidney disease</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Paediatric
Inability to exercise</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation is not concealed</concealment>
    <sequence>Computer generated random numbers</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Nil</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>54</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>4215</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Bond University</primarysponsorname>
    <primarysponsoraddress>Robina
QLD 4229</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Bond University</fundingname>
      <fundingaddress>Robina
QLD 4229</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Gold Coast Hospital</othercollaboratorname>
      <othercollaboratoraddress>108 Nerang-Southport Road, Southport
QLD 4215</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Most dialysis patients are susceptible to cardiovascular disease (CVD) because of inflammation due to the kidney disease and dialysis. Regular exercise training has been shown to reduce inflammation in healthy people and people with CVD, but as yet it is not known whether exercise can help reduce inflammation in people undertaking dialysis.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Nil</publication>
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bond University Human Research Ethics Committe</ethicname>
      <ethicaddress>Bond University
Robina
QLD 4229</ethicaddress>
      <ethicapprovaldate />
      <hrec>EC00357</hrec>
      <ethicsubmitdate>30/11/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Gold Coast District Health Service</ethicname>
      <ethicaddress>108 Southport-Nerang Road, Southport
QLD 4215</ethicaddress>
      <ethicapprovaldate />
      <hrec>EC00160</hrec>
      <ethicsubmitdate>30/11/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Neil Smart</name>
      <address>Faculty HSM
Bond University
Robina QLD 4229</address>
      <phone>+ 61 7 55954453</phone>
      <fax>+61 7 55954122</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Neil Smart</name>
      <address>Faculty Health Science and Medicine (HSM)
Bond University
Robina QLD 4229</address>
      <phone>+61 7 55954453</phone>
      <fax>+61 7 5595 4122</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Neil Smart</name>
      <address>Faculty HSM
Bond University
Robina QLD 4229</address>
      <phone>+61 7 55954453</phone>
      <fax>+61 7 55954122</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>